Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunwei Shen

Showing results (41-50 of 207) with videos related to

Pageof 21
Sort By:
British Journal of Cancer|August 21, 2023
Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 casesSiji Zhu, Yujie Lu, Xiaochun Fei, et al.
Frontiers in Surgery|May 22, 2023
Associations of clinicopathological factors with local treatment and survival outcome in elderly patients with ductal carcinoma <i>in situ</i>Xu Zhang, Yufei Zeng, Zheng Wang, et al.
Cancer Medicine|June 27, 2023
Clinical characteristics, tumor-infiltrating lymphocytes, and prognosis in HER2-low breast cancer: A comparison study with HER2-zero and HER2-positive diseaseYujie Lu, Yiwei Tong, Xiaochun Fei, et al.
Archiv Der Pharmazie|August 31, 2023
The anti-breast cancer potential of indole/isatin hybridsRuo Wang, Renhong Huang, Yaofeng Yuan, et al.
Frontiers in Oncology|March 8, 2021
Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation TreatmentSiji Zhu, Yafen Li, Weiguo Chen, et al.
Journal of Breast Cancer|October 11, 2019
Weight Gain during Neoadjuvant Chemotherapy is Associated with Worse Outcome among the Patients with Operable Breast CancerQiong Fang, Jiahui Huang, Lu Gan, et al.
Scientific Reports|February 10, 2022
Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsyHemei Zhou, Jing Yu, Xiaodong Wang, et al.
Cancer Medicine|July 14, 2020
Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomesHaoyu Wang, Jiejie Yao, Ying Zhu, et al.
Breast Cancer Research and Treatment|July 25, 2025
The feasibility and safety of fasting-mimicking diet in breast cancer patients with chemotherapy in ChinaMeiqin Xue, Nan Zhang, Xiaojing Dong, et al.
Cancer Metastasis Reviews|November 2, 2012
Stromal cells in tumor microenvironment and breast cancerYan Mao, Evan T Keller, David H Garfield, et al.
Pageof 21

Showing results (41-50 of 207) with videos related to

Sort By:
Pageof 21
British Journal of Cancer|August 21, 2023
Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 casesSiji Zhu, Yujie Lu, Xiaochun Fei, et al.
Frontiers in Surgery|May 22, 2023
Associations of clinicopathological factors with local treatment and survival outcome in elderly patients with ductal carcinoma <i>in situ</i>Xu Zhang, Yufei Zeng, Zheng Wang, et al.
Cancer Medicine|June 27, 2023
Clinical characteristics, tumor-infiltrating lymphocytes, and prognosis in HER2-low breast cancer: A comparison study with HER2-zero and HER2-positive diseaseYujie Lu, Yiwei Tong, Xiaochun Fei, et al.
Archiv Der Pharmazie|August 31, 2023
The anti-breast cancer potential of indole/isatin hybridsRuo Wang, Renhong Huang, Yaofeng Yuan, et al.
Frontiers in Oncology|March 8, 2021
Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation TreatmentSiji Zhu, Yafen Li, Weiguo Chen, et al.
Journal of Breast Cancer|October 11, 2019
Weight Gain during Neoadjuvant Chemotherapy is Associated with Worse Outcome among the Patients with Operable Breast CancerQiong Fang, Jiahui Huang, Lu Gan, et al.
Scientific Reports|February 10, 2022
Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsyHemei Zhou, Jing Yu, Xiaodong Wang, et al.
Cancer Medicine|July 14, 2020
Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomesHaoyu Wang, Jiejie Yao, Ying Zhu, et al.
Breast Cancer Research and Treatment|July 25, 2025
The feasibility and safety of fasting-mimicking diet in breast cancer patients with chemotherapy in ChinaMeiqin Xue, Nan Zhang, Xiaojing Dong, et al.
Cancer Metastasis Reviews|November 2, 2012
Stromal cells in tumor microenvironment and breast cancerYan Mao, Evan T Keller, David H Garfield, et al.
Pageof 21